At HealthNewsReview.org, Gary Schwitzer has a roundup of coverage of ...
Category: chemotherapy
At HealthNewsReview.org, Gary Schwitzer has a roundup of coverage of a study in the Annals of Oncology entitled, "Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer." Schwitzer headlines his post, "Positive spin on cancer studies--warnings to researchers, journalists, and the public."
The article's authors, from the University of Toronto, reviewed 164 Phase III randomized clinical trials of efficacy and toxicity for women with breast cancer. They found that 33% of the studies were biased in their reporting of the outcome, and 67% in the reporting of toxicity of the treatment in question. Researchers are, in other words, making their results...
Two weeks ago, I posted...
Two weeks ago, I posted an item calling out Ezekiel Emanuel, the noted oncologist, biologist, and former White House adviser, for an Op-Ed he wrote in The New York Times. I said the story, about a pressing shortage of cancer drugs, was poorly done. And I arrogantly noted that almost any journeyman science writer, with far less credentials and public esteem than Emanuel, could do a better job. "Never send a man to do a journalist's job," I wrote.
Now, it's time to do a little ground-truthing on that. A number of science...
©2010 Knight Science Journalism at MIT. All Rights Reserved.